Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23237,82,1.17 [0.80-1.73],0.4122805206670719
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23724,127,1.10 [0.79-1.53],0.5704578777130129
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23511,866,1.03 [0.90-1.17],0.6550004183993532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,23745,257,0.91 [0.71-1.18],0.4868648926968627
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23067,2333,1.01 [0.93-1.10],0.7774731645756919
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23283,1753,1.04 [0.95-1.14],0.3709572201190283
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23575,845,0.98 [0.85-1.12],0.7570420212392701
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23680,38,1.21 [0.70-2.10],0.5012599375856891
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22664,541,1.08 [0.92-1.27],0.3300466687431892
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21897,512,1.09 [0.93-1.29],0.2795489310300231
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22118,145,0.93 [0.66-1.30],0.6559577949037056
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17637,1021,0.92 [0.81-1.05],0.2104660055419202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21919,244,1.26 [1.03-1.55],0.0269970490770451
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23717,987,1.00 [0.88-1.13],0.938896757165738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,23800,312,0.90 [0.72-1.14],0.389822651668017
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23169,524,1.01 [0.86-1.20],0.8654599113949043
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23749,594,1.10 [0.94-1.28],0.2305046481538931
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22859,129,1.08 [0.78-1.51],0.640103077915442
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23842,28,0.94 [0.44-2.02],0.8781814488176524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23676,521,1.13 [0.97-1.33],0.1240607637342329
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23706,64,1.03 [0.63-1.69],0.8936423904757177
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23752,150,1.21 [0.91-1.60],0.1815592414417173
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23737,135,1.21 [0.91-1.63],0.1927912780663996
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22944,299,1.20 [0.98-1.47],0.0727816624111492
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22847,202,0.86 [0.64-1.15],0.3053900930975884
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22794,64,1.18 [0.77-1.83],0.4489558974927362
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23815,45,1.44 [0.91-2.29],0.1235361980578265
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23786,110,1.32 [0.97-1.79],0.0793954716638718
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral warts,23711,35,1.33 [0.76-2.33],0.3111899557969264
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23719,43,1.13 [0.65-1.95],0.6748862035447134
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,23591,273,0.88 [0.68-1.14],0.3329848773562485
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23767,63,0.61 [0.34-1.11],0.1045108106936403
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23739,68,1.21 [0.80-1.84],0.3678062089447126
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10623,38,0.36 [0.16-0.80],0.0117682252225914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23671,988,1.04 [0.92-1.18],0.5185284143068943
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of meninges,23830,43,1.32 [0.81-2.14],0.2592043307355648
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23810,46,0.77 [0.40-1.47],0.4294945582524568
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23822,75,0.75 [0.45-1.24],0.257100000197648
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of ovary,13162,84,1.56 [1.17-2.08],0.0026553509434712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23833,230,1.03 [0.79-1.33],0.8424216084693716
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Caecum,23830,171,0.92 [0.67-1.26],0.611589212000219
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23778,44,1.34 [0.83-2.16],0.2339953380356764
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,23838,149,1.06 [0.77-1.45],0.7210253331568259
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,23805,243,1.19 [0.95-1.50],0.1221513786231905
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23773,460,1.03 [0.86-1.23],0.779664776485244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23834,256,1.00 [0.78-1.28],0.9973394886351876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Carcinoma in situ of breast,11311,73,0.94 [0.58-1.52],0.7987182728310488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11347,80,0.94 [0.59-1.48],0.7740465004362231
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20590,31,1.41 [0.81-2.44],0.2213150048150335
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20592,33,1.18 [0.64-2.19],0.5902362549907008
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23802,92,1.07 [0.73-1.59],0.7226094087231218
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",23802,90,1.06 [0.72-1.58],0.7576057636526403
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,12613,341,1.19 [0.98-1.44],0.0812259164074262
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lung cancer and mesothelioma,17649,152,0.78 [0.55-1.12],0.1775206784112899
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Lymphoid leukaemia,20586,27,0.72 [0.30-1.72],0.4602308370313972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20686,127,0.88 [0.61-1.27],0.4974490505215728
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20634,75,0.74 [0.44-1.24],0.2472401174806587
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11396,68,1.00 [0.63-1.58],0.9985611518762556
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20603,44,1.17 [0.68-1.99],0.5717895107854691
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20606,47,1.01 [0.57-1.78],0.9804148017620132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20620,61,1.25 [0.80-1.94],0.3288405299392712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11376,48,1.37 [0.88-2.14],0.1682348586964179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20610,51,1.41 [0.92-2.17],0.1140828493987659
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9574,343,1.01 [0.81-1.26],0.9093106332344604
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20643,84,0.77 [0.47-1.24],0.2798249751371409
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20605,46,0.77 [0.41-1.48],0.4406611690340876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20613,54,0.87 [0.49-1.54],0.6367685208577873
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,23636,190,0.99 [0.74-1.32],0.9524660314301135
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of trunk,23799,86,1.02 [0.67-1.56],0.92341980441463
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanoma in situ,20569,40,1.02 [0.56-1.88],0.9417420644283988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20612,53,1.28 [0.81-2.02],0.2874359322630843
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20657,98,1.37 [0.99-1.88],0.0538605242427538
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20659,100,0.79 [0.51-1.23],0.2983226816262214
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20616,57,1.35 [0.89-2.04],0.1542319157951709
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,23686,123,1.31 [0.98-1.75],0.0717847088621605
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21105,546,1.11 [0.95-1.30],0.2035828827120854
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21132,573,1.13 [0.97-1.31],0.1265109225430993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23588,262,1.21 [0.98-1.49],0.0825578431656135
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22618,40,1.09 [0.60-1.96],0.7802401193694515
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23392,66,0.92 [0.56-1.52],0.7406632290957169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23141,1914,1.10 [1.01-1.20],0.0251177438949429
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22841,19,0.88 [0.33-2.31],0.789335581914185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23535,28,1.16 [0.58-2.31],0.6795581347068362
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23458,880,1.06 [0.94-1.21],0.3454097134424356
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23458,880,1.06 [0.94-1.21],0.3454097134424356
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22626,48,1.58 [1.08-2.32],0.0174818071660551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23602,780,1.17 [1.03-1.33],0.0143401157240663
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23600,93,1.40 [1.02-1.92],0.0385575271001329
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23374,48,0.83 [0.45-1.55],0.5614441972481159
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23365,39,1.18 [0.68-2.08],0.5544190227489321
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23673,166,1.22 [0.94-1.59],0.1370595467470788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23773,59,1.00 [0.59-1.67],0.9862986033296952
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23650,143,1.20 [0.90-1.60],0.2133093190022458
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22881,59,1.24 [0.80-1.91],0.3390390769416468
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20457,176,0.93 [0.69-1.26],0.6417363617998473
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22151,103,0.85 [0.56-1.29],0.4399473330639052
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22169,121,0.93 [0.64-1.35],0.7112189285973354
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20313,32,0.55 [0.24-1.27],0.1638770327994542
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22116,60,0.89 [0.52-1.52],0.6644276306149781
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21816,120,1.24 [0.90-1.70],0.1824359086103844
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23717,143,0.78 [0.54-1.12],0.1844522927033977
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23619,45,1.27 [0.77-2.10],0.3510242460332909
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23606,32,1.79 [1.17-2.74],0.0070557025294906
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23493,1437,0.98 [0.88-1.09],0.7001098245679511
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21346,1397,0.98 [0.89-1.09],0.7536980199821381
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20318,37,0.79 [0.39-1.60],0.5109207697412939
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22434,51,0.77 [0.42-1.43],0.4138437217083047
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20440,159,1.01 [0.74-1.37],0.9626927274299812
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20336,55,0.72 [0.39-1.31],0.2747447631399553
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22355,2074,0.90 [0.82-0.99],0.0225438885869524
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20382,101,1.07 [0.74-1.55],0.7016963555272292
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20613,332,0.99 [0.80-1.23],0.942664933560639
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23761,225,1.07 [0.84-1.38],0.570727789140629
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23627,91,0.80 [0.51-1.26],0.335936924480706
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20365,84,1.01 [0.67-1.53],0.9580465788945072
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20315,34,1.34 [0.78-2.30],0.2842155806941404
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23477,1094,1.01 [0.90-1.13],0.8702028836770754
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20393,112,1.05 [0.74-1.49],0.7739466454602077
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20412,131,1.11 [0.81-1.53],0.5070066898107901
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20624,343,0.84 [0.67-1.06],0.1405381274826305
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20334,53,0.98 [0.57-1.69],0.9367047247898604
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23621,85,0.82 [0.52-1.30],0.4068049808535676
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20536,255,1.01 [0.79-1.29],0.9335806179297022
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20549,268,0.93 [0.72-1.18],0.5312650024663836
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21747,51,1.55 [1.05-2.29],0.0268513647234
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23238,2957,0.94 [0.87-1.01],0.0815198135687886
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22407,24,1.03 [0.46-2.32],0.9441197634041448
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22436,53,0.74 [0.40-1.36],0.3294854772617992
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23686,1675,0.99 [0.89-1.09],0.7874413723870984
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23689,1672,0.99 [0.89-1.09],0.7895058470165812
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22414,31,1.02 [0.50-2.08],0.9552289796970136
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23564,1068,1.13 [1.02-1.27],0.0247369319042141
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21050,769,0.97 [0.84-1.12],0.6516087417585184
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23834,102,0.89 [0.59-1.34],0.5751736784163555
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23603,29,1.27 [0.67-2.40],0.4698193216619849
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22575,79,0.99 [0.64-1.54],0.9728586576000046
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22593,97,0.68 [0.43-1.08],0.1024531511915669
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20391,110,0.98 [0.68-1.42],0.9128180189987511
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22281,103,0.91 [0.61-1.37],0.6658252799882936
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1478,58,1.07 [0.66-1.76],0.7769420677535688
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1575,168,0.90 [0.65-1.26],0.5479332646092291
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22212,34,0.76 [0.35-1.66],0.4950005120741031
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1449,29,0.95 [0.43-2.10],0.901161973695106
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23484,1306,0.92 [0.82-1.03],0.1494638557248516
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23632,58,1.29 [0.84-1.99],0.2458840247317241
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21937,241,0.88 [0.67-1.16],0.3643864086599173
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20622,341,1.00 [0.81-1.24],0.9705066938562872
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23764,148,0.86 [0.61-1.22],0.3913392429534233
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23186,48,1.42 [0.90-2.24],0.1319894385225986
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,22740,692,0.94 [0.80-1.09],0.4117530877016979
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23229,91,1.32 [0.93-1.87],0.1160596472685833
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23168,30,1.43 [0.80-2.54],0.2256215705742856
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23234,96,0.99 [0.66-1.48],0.9586458240771404
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16918,787,0.98 [0.84-1.13],0.7369343639471254
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,AV-block,21689,158,1.06 [0.78-1.44],0.7006598121226669
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23812,224,0.89 [0.68-1.18],0.4261596388876728
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,16226,95,1.29 [0.90-1.86],0.1715274850675175
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21642,111,1.04 [0.72-1.50],0.8435693553793697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21602,71,1.15 [0.75-1.76],0.5121440057852145
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23844,15,0.82 [0.28-2.43],0.720062005494124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,21991,460,0.92 [0.76-1.11],0.3836722617045577
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23204,1166,0.97 [0.87-1.09],0.6365769370707709
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22147,5244,0.99 [0.94-1.04],0.686920755223771
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22845,156,0.89 [0.63-1.24],0.4783059242192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Endocarditis,21570,39,1.33 [0.81-2.18],0.2558964994346532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23735,444,1.02 [0.85-1.22],0.8372756455700179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,22642,4263,1.00 [0.94-1.06],0.9688342664941288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22649,4270,1.00 [0.94-1.06],0.9997166940398752
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23691,47,1.13 [0.68-1.89],0.6329521783411702
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18456,77,1.42 [1.03-1.95],0.0326253067902683
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18419,40,1.29 [0.78-2.13],0.3262724952729766
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,23756,587,0.96 [0.82-1.14],0.6569114427226729
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23375,56,0.84 [0.47-1.49],0.5438014612006117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23348,1300,0.97 [0.87-1.09],0.6341524466689197
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23645,275,0.86 [0.66-1.11],0.2371805604723886
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21710,179,0.82 [0.59-1.13],0.2169121117819878
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23620,519,0.96 [0.80-1.14],0.6381205450671881
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22469,421,0.93 [0.76-1.13],0.4631089119006353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23793,102,1.00 [0.67-1.48],0.9949089655180234
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23829,179,1.02 [0.76-1.37],0.8869000292400766
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,22720,31,0.92 [0.44-1.91],0.8190298016560351
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other aneurysm,23181,43,1.16 [0.67-2.01],0.6011373849311974
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,21753,222,1.08 [0.84-1.39],0.5553480073461688
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23199,61,1.24 [0.79-1.92],0.3485152471909637
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23265,127,1.11 [0.80-1.54],0.5157196750835178
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21640,109,1.04 [0.72-1.49],0.8496679218725401
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,22752,63,1.01 [0.61-1.66],0.9785814848759544
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22735,46,1.57 [1.03-2.39],0.0344577556216635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23157,32,0.79 [0.36-1.71],0.5497781055303428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22769,80,1.04 [0.68-1.61],0.8467815228772089
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22043,512,1.06 [0.89-1.25],0.5230189063148958
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23207,38,0.69 [0.33-1.42],0.3083457019902803
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23441,303,0.94 [0.75-1.19],0.6231300294661928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23453,133,1.35 [1.04-1.76],0.0253339322103551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23328,203,1.03 [0.79-1.35],0.8283404848418271
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16340,209,1.11 [0.85-1.45],0.4413088327900535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23298,181,1.02 [0.76-1.36],0.8980867475438152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22904,215,0.97 [0.74-1.28],0.8496602937215123
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23608,288,1.07 [0.86-1.34],0.5555791716156617
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23804,278,0.94 [0.74-1.20],0.6213114846023076
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21677,146,0.91 [0.65-1.29],0.6014530963454104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23450,130,1.38 [1.06-1.79],0.0170018040158109
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23227,102,0.63 [0.40-1.00],0.0485242835128475
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23639,320,0.84 [0.66-1.07],0.1579419254849037
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23617,352,0.84 [0.67-1.06],0.144594549689084
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23355,48,0.78 [0.42-1.46],0.4420217701194693
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23186,49,1.03 [0.59-1.80],0.922914976271366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23487,117,0.65 [0.42-0.99],0.0450582840391983
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23258,157,1.06 [0.78-1.43],0.7227195426810524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,22948,259,1.14 [0.91-1.43],0.2659416257934127
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23149,47,0.72 [0.38-1.37],0.3178039594591663
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23689,450,1.03 [0.86-1.24],0.7140856800742206
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23697,323,0.88 [0.69-1.11],0.2672882077059112
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21215,1222,1.10 [0.99-1.22],0.0836819697011278
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,23183,3190,0.99 [0.93-1.06],0.8557894183902757
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23642,374,0.88 [0.71-1.09],0.2542606891182992
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21458,1465,0.97 [0.88-1.08],0.5762180273823341
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20067,74,1.01 [0.64-1.59],0.9805780604290956
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,23358,1333,1.00 [0.90-1.11],0.9745337021049808
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21521,1528,0.98 [0.89-1.08],0.6860153912888205
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Vascular dementia,23744,15,0.47 [0.14-1.64],0.2394691974980509
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Alzheimer disease,23843,63,1.32 [0.88-1.99],0.1750515701045075
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Bell's palsy,22380,67,1.28 [0.86-1.91],0.227301531775594
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22735,422,1.05 [0.87-1.26],0.622244831258927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral cysts,23532,178,0.98 [0.73-1.32],0.8811075410822554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23769,195,0.95 [0.71-1.27],0.7179184093243738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23714,22,1.85 [1.15-2.97],0.0111770491635241
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23833,43,1.08 [0.61-1.91],0.803776808419835
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23405,51,0.93 [0.52-1.65],0.8051742889168212
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,22502,227,0.83 [0.62-1.10],0.1896364870762693
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23421,1146,1.00 [0.89-1.12],0.9851921303517815
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23818,167,0.92 [0.67-1.26],0.5901204926346175
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23402,1424,1.01 [0.91-1.12],0.8947557996020743
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,23521,49,0.99 [0.55-1.76],0.9615305944278876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,23717,143,0.96 [0.68-1.34],0.7996778020900114
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hydrocephalus,23397,43,1.21 [0.72-2.06],0.4716940098300274
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23821,59,1.30 [0.85-2.00],0.2222375919738099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22383,70,0.74 [0.44-1.26],0.2673048697070658
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22386,73,1.20 [0.80-1.81],0.3719952463718432
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Memory loss,23713,64,0.88 [0.52-1.48],0.6212437467118204
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,22633,358,1.18 [0.98-1.42],0.0818925907621112
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23769,324,1.17 [0.96-1.43],0.1154275042737273
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Motor neuron disease,17320,91,1.17 [0.80-1.71],0.4119492131111142
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23652,129,1.05 [0.75-1.47],0.7777677828305762
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23304,991,1.03 [0.91-1.16],0.6468570615806499
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,22570,2622,0.98 [0.90-1.06],0.5480981887312447
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23756,64,1.23 [0.80-1.89],0.3408345345378601
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22648,335,1.08 [0.88-1.32],0.4832568020266826
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23779,199,0.93 [0.70-1.24],0.6272625421712171
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19882,276,1.19 [0.96-1.47],0.1101723140627735
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23406,52,0.72 [0.39-1.34],0.3022616777721686
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23455,101,1.16 [0.81-1.65],0.4162413342209569
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23724,73,0.94 [0.59-1.50],0.7939418303312143
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22397,84,1.28 [0.89-1.84],0.1812129680071675
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other headache syndromes,22331,56,0.87 [0.49-1.53],0.6238030138957847
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,23738,384,1.01 [0.83-1.23],0.9082239737318812
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,22776,501,1.06 [0.89-1.26],0.5150514185395412
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Parkinson's disease,23832,75,0.84 [0.51-1.38],0.4827052052561892
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23409,55,1.28 [0.82-2.01],0.2828149050421046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,23842,34,0.89 [0.44-1.80],0.7504253421614245
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,23631,437,1.04 [0.87-1.24],0.6861403151009045
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23610,30,1.67 [1.04-2.68],0.0323257618434534
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23828,117,1.05 [0.74-1.50],0.7788972659543107
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22341,28,1.41 [0.81-2.47],0.2290520864316003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23843,64,1.32 [0.88-1.98],0.1761416625662995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23732,14,0.57 [0.16-2.00],0.3765747519531562
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23421,35,1.12 [0.61-2.07],0.7158382663725013
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23530,186,1.08 [0.82-1.42],0.5772416572731334
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23770,171,0.78 [0.55-1.09],0.1446678334684217
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23196,32,1.26 [0.71-2.24],0.4263160744808693
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23230,66,0.80 [0.47-1.38],0.4278070263687022
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23764,29,0.60 [0.25-1.45],0.2581346377731486
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23675,57,0.85 [0.48-1.49],0.5656553394827337
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1452,32,0.96 [0.45-2.04],0.9065513285617056
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1723,68,1.11 [0.71-1.74],0.633986211156301
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23461,75,1.01 [0.64-1.58],0.9754596210363494
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23736,539,0.74 [0.61-0.90],0.0019821853749309
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23578,414,0.99 [0.82-1.21],0.9448453426858716
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23285,121,1.28 [0.94-1.72],0.1143030736675168
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23763,419,1.02 [0.84-1.23],0.8474913007311456
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23835,48,1.49 [0.97-2.28],0.0684458433366844
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23695,351,1.09 [0.89-1.33],0.419654103657747
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23807,189,0.87 [0.64-1.18],0.3801194066941681
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23785,114,0.89 [0.60-1.32],0.5556627170936947
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23179,15,0.77 [0.25-2.38],0.6449857051436101
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23189,25,1.00 [0.45-2.21],0.9973734519824942
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23194,30,1.20 [0.64-2.27],0.5662437204711446
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23801,337,1.04 [0.84-1.28],0.7239971164108605
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23548,84,1.44 [1.03-2.01],0.0342552543080158
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23365,21,0.80 [0.31-2.04],0.640012127611147
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23679,61,0.99 [0.59-1.64],0.961061328796976
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23748,130,0.80 [0.55-1.17],0.2523077659260475
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23487,143,1.17 [0.87-1.58],0.2984489704821272
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23733,62,1.00 [0.60-1.65],0.9946981806175076
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23683,219,0.93 [0.70-1.22],0.583702460464715
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23483,97,1.23 [0.87-1.75],0.2487615042223863
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23239,940,0.97 [0.85-1.10],0.6422499577790202
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23727,109,0.64 [0.42-1.00],0.0496528273040996
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23821,101,1.27 [0.91-1.78],0.1523520658653439
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23392,228,1.11 [0.87-1.41],0.4119851479625676
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23653,35,1.41 [0.83-2.38],0.2021160957017197
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23819,32,1.46 [0.86-2.47],0.1605333550068213
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23200,36,1.35 [0.80-2.28],0.2587389501014899
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23265,101,1.10 [0.76-1.58],0.6231789254088906
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23255,58,0.95 [0.55-1.61],0.8373476626909986
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23394,50,0.68 [0.36-1.30],0.2425976399579855
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23244,47,0.99 [0.56-1.76],0.9805895449324696
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23510,46,0.58 [0.29-1.16],0.121454628544741
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23544,80,1.11 [0.73-1.70],0.6133474530019059
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23240,76,0.87 [0.53-1.41],0.5670625394447899
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23300,103,0.91 [0.61-1.37],0.6533728827187036
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23226,29,1.26 [0.67-2.37],0.4685275663286143
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23012,713,1.01 [0.87-1.17],0.9031758555775388
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23208,44,1.25 [0.75-2.08],0.3922239866113062
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23654,268,0.97 [0.76-1.24],0.8118299275646033
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23416,30,0.43 [0.18-1.05],0.0646972258242533
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23493,107,0.89 [0.60-1.33],0.5612229864829092
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23664,55,0.92 [0.53-1.61],0.7671658344120934
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23805,81,1.14 [0.76-1.70],0.5304952338051816
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23737,126,0.62 [0.41-0.94],0.0248506305800384
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23658,49,0.86 [0.47-1.57],0.625806395011615
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23659,50,1.26 [0.79-2.00],0.3286943335317755
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23757,459,1.01 [0.84-1.21],0.9007664636324104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23585,287,1.00 [0.80-1.26],0.968716754506308
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23382,84,1.18 [0.80-1.74],0.4126137777541926
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23364,66,1.16 [0.75-1.78],0.5055595685905765
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,23590,69,0.99 [0.61-1.59],0.9590711957262468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23729,208,0.91 [0.68-1.21],0.4979037658721532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23577,56,0.95 [0.55-1.64],0.8623425742576176
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza,22720,68,0.91 [0.56-1.49],0.7225373880993751
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22719,67,0.92 [0.56-1.50],0.7250274829099055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17615,118,1.00 [0.69-1.43],0.9806563050096124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,23718,274,0.98 [0.77-1.25],0.8683127993119223
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18899,1530,1.02 [0.92-1.12],0.7315087320266495
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18999,1502,1.01 [0.92-1.12],0.8208015867191666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23597,84,1.23 [0.85-1.79],0.2696320846284661
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22701,49,1.26 [0.78-2.04],0.3469893811109216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Bronchiectasis,21192,156,0.95 [0.69-1.31],0.7589854774975606
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21071,35,1.07 [0.57-2.02],0.8370913537097711
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23078,2042,1.03 [0.94-1.12],0.5369134934635467
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22550,59,1.37 [0.90-2.07],0.1414325017247168
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,22635,144,1.15 [0.85-1.55],0.3580108997633106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23759,627,1.03 [0.89-1.20],0.6701577539570249
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22609,118,0.74 [0.49-1.12],0.152333420003311
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22158,3688,0.99 [0.93-1.06],0.8278174387481174
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22829,338,0.87 [0.69-1.10],0.2447314343886281
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,23582,450,1.07 [0.90-1.28],0.4239336678797137
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Emphysema,21194,158,1.19 [0.91-1.55],0.2120551891803452
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22715,97,0.71 [0.45-1.12],0.1438401243198298
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23685,1033,0.95 [0.84-1.07],0.3942898038807089
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22737,119,0.91 [0.62-1.32],0.6156952158900011
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Later onset COPD,22573,177,0.93 [0.69-1.24],0.6218505775859595
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23836,135,1.05 [0.76-1.46],0.7551813042716813
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,22595,104,1.21 [0.86-1.71],0.2634396007786045
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23651,558,1.09 [0.93-1.27],0.2694039950702704
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,23684,1090,0.99 [0.88-1.11],0.8651747265003991
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23274,783,1.01 [0.88-1.16],0.8668841414864552
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other pleural conditions,22627,33,0.99 [0.50-1.97],0.9779090364903305
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23790,175,1.04 [0.78-1.38],0.8012046694433881
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23768,741,0.93 [0.80-1.08],0.3414984211569293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,23120,526,1.08 [0.91-1.27],0.3842169920457873
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural plaque,22641,47,0.94 [0.52-1.70],0.8307345443960613
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23500,848,0.96 [0.84-1.10],0.5650448391877467
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23819,118,0.98 [0.68-1.41],0.9106306724725084
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pneumothorax,22650,56,1.11 [0.68-1.81],0.6769826999137571
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pollen allergy,23814,235,1.06 [0.83-1.37],0.6276391515332309
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,23651,36,1.36 [0.82-2.25],0.2302459878102636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17528,31,1.38 [0.81-2.34],0.2305292114060926
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23631,538,1.11 [0.95-1.30],0.1868055470162105
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22765,274,0.98 [0.77-1.24],0.850783192903209
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Viral pneumonia,22816,164,0.80 [0.57-1.13],0.2050599068759078
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23613,140,0.78 [0.54-1.13],0.1979546377085727
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13724,84,1.09 [0.72-1.65],0.697197332560892
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18233,57,0.66 [0.36-1.21],0.1782154374630554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,23669,130,1.16 [0.85-1.59],0.3349891041792342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute gastritis,19054,59,1.42 [0.97-2.07],0.0702969455424526
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,22447,148,0.82 [0.58-1.16],0.2657353796989942
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute peritonitis,23457,61,1.20 [0.78-1.87],0.4081677896449687
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23174,73,1.42 [0.99-2.02],0.053833417933095
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,19302,307,1.17 [0.96-1.43],0.1164041777540795
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22345,46,1.46 [0.94-2.25],0.0914916037562774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23485,46,1.45 [0.94-2.25],0.092901463739872
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,22450,151,0.97 [0.70-1.33],0.8339644043617109
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,23114,815,1.01 [0.89-1.15],0.8722582214501196
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,19210,215,1.07 [0.83-1.39],0.5912425928168556
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22335,36,0.92 [0.46-1.84],0.8076074216201717
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23716,72,0.86 [0.53-1.40],0.5390638345676618
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,22596,96,1.24 [0.88-1.74],0.215636948594444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Collagenous colitis,22477,47,1.32 [0.84-2.10],0.2309712946262798
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23673,180,1.04 [0.78-1.39],0.7900624820956542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,23656,1004,1.06 [0.94-1.20],0.3104934024009196
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,22511,81,1.21 [0.83-1.78],0.3200737367416618
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23534,53,1.12 [0.68-1.85],0.6427331825556613
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22507,77,1.19 [0.80-1.77],0.3784464785712108
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,23117,229,0.92 [0.70-1.21],0.5423771993435003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22034,1561,1.03 [0.94-1.14],0.4876645616132498
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,23706,167,1.07 [0.80-1.43],0.6622959801167155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,23736,635,1.04 [0.89-1.21],0.6122424198494432
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22326,3331,1.02 [0.95-1.09],0.6102126588005152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23416,528,0.90 [0.75-1.08],0.2511183765141865
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23768,372,0.88 [0.71-1.09],0.2298302037197208
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23003,115,1.10 [0.78-1.55],0.5770427622875993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22864,61,0.57 [0.31-1.04],0.0665219202370497
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23591,1091,1.13 [1.02-1.27],0.0251733430351101
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of tongue,22869,107,1.05 [0.73-1.51],0.7867563972082081
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23395,1096,1.02 [0.91-1.14],0.7513584474174044
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20289,2113,1.03 [0.94-1.12],0.5403974253334956
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,19125,130,0.81 [0.56-1.18],0.2795635471244306
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23781,101,0.77 [0.50-1.20],0.2522389249868452
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23727,72,1.14 [0.74-1.75],0.5495867704494868
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23191,90,0.83 [0.53-1.29],0.4076111425427099
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18330,154,1.03 [0.75-1.40],0.8679167132782452
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,19438,443,0.96 [0.80-1.17],0.7057653475507667
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,19240,245,1.06 [0.84-1.34],0.6284834057556439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20953,1958,0.99 [0.91-1.08],0.806271153908479
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19353,358,0.96 [0.78-1.18],0.6954818301117439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19402,6915,1.01 [0.96-1.05],0.7836410377244056
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,23377,877,1.10 [0.97-1.24],0.1539927266624201
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22950,62,0.95 [0.57-1.58],0.8368473008440968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18957,1097,1.09 [0.97-1.22],0.1487251721858258
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23147,46,1.18 [0.70-1.99],0.531476120326995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,22834,2361,0.99 [0.92-1.08],0.853968752807119
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,23736,67,1.17 [0.75-1.81],0.4830280926449776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impaction of intestines,18208,32,0.99 [0.50-1.95],0.9716260405454806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,21069,596,0.98 [0.83-1.16],0.8302621827950925
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20543,70,0.77 [0.45-1.30],0.3244362981504346
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18239,63,1.04 [0.64-1.69],0.8687976497217794
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22616,116,1.26 [0.93-1.71],0.1349489001386032
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18682,506,1.01 [0.85-1.20],0.8965914755942085
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23818,328,0.99 [0.80-1.23],0.9589513236198672
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23037,607,1.08 [0.93-1.25],0.3128540494395534
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23196,766,1.04 [0.91-1.19],0.5724835769435738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19122,127,0.99 [0.70-1.41],0.958431939619174
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,19420,425,1.18 [1.00-1.40],0.050417128999735
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23803,116,0.88 [0.60-1.30],0.5211861088557748
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20516,43,0.99 [0.54-1.80],0.9756890530582546
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19301,1125,1.15 [1.03-1.28],0.0106187136556574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22468,169,1.12 [0.84-1.47],0.4399711012666005
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22436,137,0.62 [0.42-0.92],0.0188159884512221
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,19483,1307,0.98 [0.88-1.10],0.7802810319189246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,22406,4230,1.02 [0.96-1.08],0.5745161060965753
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22866,168,0.84 [0.61-1.17],0.3117037089565059
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,23608,507,1.01 [0.85-1.20],0.8854208219960258
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19461,466,1.14 [0.97-1.35],0.1148895953286563
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22373,74,1.01 [0.64-1.58],0.9668145899410236
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23720,324,0.82 [0.65-1.04],0.0970208496972642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19657,662,1.02 [0.88-1.18],0.7931136556018222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23391,891,1.10 [0.97-1.24],0.142434980990977
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23035,147,0.78 [0.55-1.13],0.1872275390901859
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19225,1049,1.06 [0.95-1.19],0.295705401886484
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20514,1519,1.04 [0.94-1.14],0.4561277346618353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23169,68,0.79 [0.47-1.34],0.3842707499938002
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23095,665,1.10 [0.96-1.27],0.1680267328315173
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18383,207,1.03 [0.79-1.34],0.8355742699953749
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23712,83,1.08 [0.72-1.64],0.7022054317098281
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18482,306,1.02 [0.82-1.27],0.8623970951575166
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22620,120,1.05 [0.74-1.49],0.7899282034753936
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23833,56,1.04 [0.62-1.73],0.8883058220544049
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22902,118,1.12 [0.80-1.57],0.5020000328519472
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Toxic colitis,22453,23,1.00 [0.44-2.28],0.9993329859272332
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19160,165,1.07 [0.80-1.43],0.6490486149862535
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,22563,133,0.79 [0.54-1.16],0.2250461808288172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22545,115,0.74 [0.49-1.13],0.1623449409759234
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,20710,237,1.01 [0.78-1.31],0.9205627502853322
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18270,94,0.98 [0.66-1.46],0.93741757768332
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,20674,201,0.88 [0.66-1.18],0.4013747733601288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Volvulus,18234,58,0.57 [0.31-1.07],0.0796783093701409
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23801,132,1.37 [1.04-1.80],0.0236797375295888
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23610,72,0.67 [0.39-1.14],0.1428673165030584
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22571,129,1.10 [0.80-1.52],0.5656972855636772
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23270,475,0.93 [0.78-1.12],0.4744569363311429
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22976,181,1.10 [0.83-1.46],0.5151292199016761
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22591,149,0.79 [0.56-1.13],0.1956411876368766
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23620,206,1.14 [0.89-1.46],0.3147692596298446
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23756,342,1.11 [0.91-1.35],0.3046314656247113
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23450,36,0.81 [0.40-1.65],0.5580202099167382
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22554,2217,1.07 [0.99-1.16],0.1005476627028892
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23435,372,1.13 [0.94-1.37],0.2020610091279138
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23327,264,1.07 [0.84-1.35],0.59704879402331
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23485,690,0.97 [0.83-1.13],0.6760008365615355
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23831,40,1.00 [0.54-1.86],0.9905622786024924
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22497,55,1.41 [0.93-2.13],0.1064093677723152
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23097,34,1.73 [1.15-2.59],0.0080108386989826
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23614,200,1.15 [0.89-1.48],0.2746923664570257
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22690,248,1.16 [0.93-1.46],0.1946691696717113
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22475,33,0.53 [0.23-1.21],0.1325001474724337
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23768,63,1.51 [1.07-2.13],0.0201264728306082
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22915,120,0.99 [0.69-1.43],0.9619988356415374
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23671,133,1.02 [0.73-1.42],0.8985892949726035
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23438,24,1.55 [0.90-2.65],0.1136891762955478
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22486,44,0.93 [0.50-1.74],0.8246279848572813
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23396,954,1.10 [0.98-1.24],0.1113335654755933
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22720,278,1.17 [0.94-1.45],0.1558003755619488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22479,37,0.52 [0.24-1.16],0.1094748552216928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23769,231,0.98 [0.76-1.27],0.8776641306820571
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23468,54,1.23 [0.77-1.97],0.3806357192369047
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23727,189,0.95 [0.71-1.27],0.7194674358909368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23816,147,1.33 [1.02-1.74],0.0336486137383643
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22550,108,1.15 [0.81-1.61],0.4337515583692569
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22605,163,1.24 [0.95-1.62],0.1160629604536518
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23810,141,1.38 [1.06-1.80],0.015092981713895
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22557,115,1.35 [1.01-1.79],0.0397367303882118
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23812,107,1.39 [1.04-1.85],0.0268195500303259
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20893,114,0.82 [0.55-1.22],0.3262860116186891
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22222,4043,1.00 [0.94-1.06],0.951926133236568
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21056,2877,0.98 [0.91-1.06],0.6695926197509655
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20861,82,1.14 [0.76-1.71],0.5178000203914448
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21372,135,1.25 [0.93-1.67],0.1330697625746374
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21380,143,1.26 [0.95-1.66],0.1118990850298972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23636,103,1.06 [0.72-1.55],0.7820145071954927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21279,42,0.89 [0.48-1.67],0.7191157537749646
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18848,669,0.95 [0.81-1.11],0.5055392974433954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23787,115,1.04 [0.74-1.48],0.810271551454737
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21491,254,0.79 [0.60-1.03],0.0858781386799724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20813,5403,1.00 [0.95-1.05],0.952382109514414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22624,91,0.86 [0.55-1.33],0.4946285951078387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20881,102,1.11 [0.77-1.59],0.5737331682734332
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21314,535,1.18 [1.02-1.37],0.029472558246179
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23059,1822,0.97 [0.88-1.06],0.5059138118207522
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20977,198,1.12 [0.86-1.45],0.4126361042106921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21039,260,0.97 [0.76-1.23],0.7880167789237995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20915,136,0.83 [0.58-1.20],0.3345756155198242
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23373,34,1.35 [0.80-2.31],0.2639863093458265
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19324,1145,1.06 [0.96-1.19],0.2561705114169809
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18509,330,1.11 [0.90-1.38],0.3141759440614287
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23793,320,1.13 [0.91-1.39],0.267147111183189
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18246,67,1.13 [0.72-1.76],0.6043945764237414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18481,302,1.10 [0.89-1.35],0.3882517407055409
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21067,288,1.00 [0.79-1.26],0.9917083738812252
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18849,670,1.04 [0.89-1.21],0.6124269222237868
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21262,25,0.75 [0.31-1.80],0.5130484719775299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21728,491,0.97 [0.81-1.16],0.737654784770319
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21487,250,1.19 [0.96-1.48],0.1208190925781397
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18799,620,1.04 [0.89-1.22],0.5844685583081063
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20849,70,1.08 [0.69-1.70],0.7248756465254269
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20832,53,0.85 [0.47-1.53],0.5933916226633595
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22584,51,1.00 [0.58-1.74],0.9864611935242248
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23552,1019,1.00 [0.88-1.13],0.9509461672968516
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23111,578,1.00 [0.85-1.18],0.9929799811366374
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23740,303,0.89 [0.71-1.13],0.3452709391142511
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19732,1553,0.95 [0.86-1.05],0.3516729208392584
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18246,67,0.60 [0.33-1.06],0.0796683848413759
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20849,70,1.20 [0.79-1.83],0.3983889072613935
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18205,26,1.31 [0.72-2.39],0.3767135778705416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18279,100,0.91 [0.60-1.36],0.6333389517741778
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22743,210,0.94 [0.71-1.25],0.6655677923318677
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22748,215,1.16 [0.92-1.48],0.2149310909681639
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23810,75,1.04 [0.67-1.60],0.8726165756325728
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22606,1369,0.98 [0.88-1.09],0.7378067602209799
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20887,108,0.95 [0.64-1.41],0.8010979348691468
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18285,106,1.01 [0.70-1.46],0.9427299287950194
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21795,558,0.98 [0.83-1.15],0.7817991083067104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19970,1791,1.06 [0.97-1.16],0.2095906335385733
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23390,51,1.33 [0.85-2.06],0.2088430826882336
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23818,69,0.62 [0.36-1.08],0.0946439383726367
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20847,68,1.44 [1.02-2.03],0.0385570175517711
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21743,964,1.06 [0.94-1.20],0.3396842534903266
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20837,58,0.83 [0.48-1.45],0.5191581127132769
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19154,975,1.05 [0.93-1.18],0.4500216309271169
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22630,97,0.70 [0.44-1.11],0.1292170269560294
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20837,58,1.28 [0.83-1.98],0.2592948931791964
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21340,103,1.09 [0.77-1.56],0.6273090232539877
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21124,345,1.13 [0.94-1.38],0.1986889641788274
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23524,185,1.15 [0.89-1.49],0.2925318954300457
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21652,415,1.03 [0.85-1.24],0.7484724868782153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23749,288,0.93 [0.74-1.18],0.5718043853212504
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23827,33,1.03 [0.53-1.99],0.9402103357856636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20961,182,1.53 [1.25-1.87],3.333665509029228e-05
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19097,537,1.05 [0.89-1.23],0.5982827391532286
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21212,433,1.09 [0.92-1.31],0.3250360181148459
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20926,147,1.07 [0.78-1.46],0.6891211817972536
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18213,34,1.18 [0.64-2.17],0.6023800105974579
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19713,1534,1.02 [0.93-1.13],0.6767441543418167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18569,390,0.95 [0.79-1.16],0.6333908510041841
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23413,74,1.15 [0.77-1.73],0.4927486670799612
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23778,43,1.15 [0.68-1.94],0.6043825568590111
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22438,26,1.14 [0.58-2.24],0.6953049286160509
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18250,71,0.66 [0.38-1.14],0.1333414529213131
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21319,82,1.02 [0.66-1.56],0.9395958269288912
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18486,307,0.89 [0.70-1.12],0.3174956255883965
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21018,239,1.07 [0.84-1.36],0.5801647803161962
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21430,193,1.07 [0.82-1.40],0.59871060823714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21331,94,0.83 [0.54-1.29],0.4108841125859186
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20133,41,0.54 [0.25-1.14],0.1041612082427775
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23830,36,1.13 [0.62-2.05],0.693637061125923
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21303,524,0.98 [0.83-1.17],0.8620812443750833
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23417,78,1.26 [0.87-1.83],0.2278669610648664
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22901,2122,1.04 [0.96-1.13],0.3747169689239114
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20879,100,1.01 [0.69-1.49],0.9497133034252788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21554,317,0.84 [0.66-1.06],0.1390016766059623
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22596,166,1.24 [0.96-1.60],0.1029519887221734
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21369,132,1.03 [0.74-1.43],0.8733705830282162
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22166,929,0.95 [0.83-1.08],0.450010172844339
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21840,603,1.00 [0.85-1.16],0.950188452459968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20818,39,1.37 [0.82-2.29],0.2221665242878773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23480,141,1.41 [1.10-1.82],0.0071107524206525
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20914,135,1.15 [0.84-1.55],0.3819114408228137
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20833,54,1.15 [0.71-1.84],0.5734114885216055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18211,32,0.58 [0.25-1.35],0.2031545170974398
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23392,722,1.09 [0.95-1.25],0.2061453311087354
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9712,64,1.29 [0.85-1.94],0.2284274207166327
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12887,70,1.29 [0.87-1.90],0.1996684759866515
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23589,272,0.98 [0.77-1.25],0.8899360945580822
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23373,56,1.19 [0.74-1.90],0.4815923495718293
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23217,547,1.18 [1.01-1.36],0.032819500155923
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23686,17,1.12 [0.46-2.71],0.8048075555649494
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23699,159,1.00 [0.73-1.37],0.9984949399082272
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,21906,133,0.93 [0.66-1.32],0.6930887155939811
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dialysis,22713,43,1.72 [1.19-2.49],0.003672812287201
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10297,979,1.20 [1.07-1.34],0.0024723964803811
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12987,170,0.93 [0.68-1.27],0.6317771729321693
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,9763,115,1.16 [0.84-1.61],0.3659493442212613
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9978,330,1.01 [0.82-1.24],0.9361393001240408
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10026,378,1.03 [0.85-1.25],0.7551141475153211
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20109,3652,1.03 [0.97-1.10],0.3802164639498289
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23725,56,0.92 [0.53-1.60],0.7669866606920144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,9389,71,1.17 [0.75-1.81],0.4905963232737039
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22590,190,1.01 [0.76-1.34],0.9581127216036144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9970,652,1.24 [1.08-1.43],0.0024723850240517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12873,208,1.01 [0.78-1.32],0.926147243624062
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9409,91,1.29 [0.89-1.86],0.1748633386666199
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,12888,106,0.98 [0.67-1.44],0.9196825662941474
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9905,257,1.00 [0.78-1.27],0.9879493739946912
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21830,57,0.72 [0.40-1.30],0.2778927251734014
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10859,1211,0.98 [0.87-1.10],0.7178427149943827
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9365,47,1.54 [1.02-2.32],0.0405303065019041
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9731,83,0.80 [0.50-1.29],0.3695763495527516
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23834,34,0.74 [0.35-1.59],0.4426873857926017
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23838,37,1.18 [0.67-2.08],0.5747850898307696
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23090,1317,0.97 [0.87-1.09],0.6435601695474407
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22192,419,1.00 [0.82-1.21],0.9935783665209056
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12869,52,0.54 [0.28-1.06],0.0723528991765533
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23797,257,1.09 [0.86-1.37],0.4845414082361216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9453,135,1.38 [1.05-1.81],0.0214869642407627
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9422,104,0.90 [0.59-1.36],0.61208823198351
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9382,64,1.36 [0.89-2.07],0.1508371617220185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23810,45,0.88 [0.48-1.62],0.6756740809360143
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22740,967,0.98 [0.86-1.11],0.730673816969599
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12771,106,1.02 [0.70-1.48],0.9208804167208908
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9716,68,0.93 [0.57-1.51],0.7565850930232881
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9845,197,0.94 [0.70-1.25],0.6491534666013894
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9700,52,0.94 [0.54-1.64],0.835182704588554
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9738,90,0.62 [0.38-1.01],0.052764056869412
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22621,221,1.04 [0.80-1.34],0.7942583994947714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23627,87,1.09 [0.73-1.63],0.658118604956697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9806,158,1.05 [0.77-1.42],0.7683039473354479
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9716,68,0.76 [0.45-1.29],0.3044574080251776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10006,358,1.13 [0.93-1.36],0.2139930486898777
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9705,57,0.65 [0.35-1.20],0.1686750770446439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9965,317,0.89 [0.71-1.12],0.3322233541360148
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23710,41,1.05 [0.58-1.90],0.8608667820576257
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9409,91,0.77 [0.48-1.22],0.2637183786351745
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23687,1287,1.07 [0.96-1.19],0.2048293676536994
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22522,122,1.05 [0.75-1.47],0.7851102546542639
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22726,56,1.15 [0.72-1.85],0.5642297349387517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23379,62,0.99 [0.60-1.65],0.9695395327100644
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21918,145,0.93 [0.66-1.31],0.6860058454765455
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23647,330,1.02 [0.82-1.27],0.8454331785143107
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9734,86,1.08 [0.73-1.59],0.7119256209334734
